MedPath

Asenapine

These highlights do not include all the information needed to use ASENAPINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ASENAPINE SUBLINGUAL TABLETS. ASENAPINE sublingual tablets Initial U.S. Approval: 2009

Approved
Approval ID

16e1cc9f-7699-49ea-b179-acb65e162304

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 2, 2021

Manufacturers
FDA

Alembic Pharmaceuticals Inc.

DUNS: 079288842

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Asenapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-198
Application NumberANDA206098
Product Classification
M
Marketing Category
C73584
G
Generic Name
Asenapine
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateSeptember 2, 2021
FDA Product Classification

INGREDIENTS (7)

POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
ASENAPINEActive
Quantity: 5 mg in 1 1
Code: JKZ19V908O
Classification: ACTIB
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDInactive
Code: 2165RE0K14
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UI
Classification: IACT

Asenapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-544
Application NumberANDA206098
Product Classification
M
Marketing Category
C73584
G
Generic Name
Asenapine
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateSeptember 2, 2021
FDA Product Classification

INGREDIENTS (7)

BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
ASENAPINEActive
Quantity: 2.5 mg in 1 1
Code: JKZ19V908O
Classification: ACTIB
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDInactive
Code: 2165RE0K14
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UI
Classification: IACT

Asenapine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62332-199
Application NumberANDA206098
Product Classification
M
Marketing Category
C73584
G
Generic Name
Asenapine
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateSeptember 2, 2021
FDA Product Classification

INGREDIENTS (7)

POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
ASENAPINEActive
Quantity: 10 mg in 1 1
Code: JKZ19V908O
Classification: ACTIB
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDInactive
Code: 2165RE0K14
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UI
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Asenapine - FDA Drug Approval Details